ProShares S&P 500 ex-Health Care ETF
SPXV
3 hedge funds and large institutions have $44K invested in ProShares S&P 500 ex-Health Care ETF in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
36.51% less ownership
Funds ownership: 40.83% → 4.31% (-37%)
89% less capital invested
Capital invested by funds: $383K → $44K (-$339K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$37K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.65K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$65 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$383K |
SPXV Hedge Fund Activity: Q4 2019 in Review
3 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ProShares S&P 500 ex-Health Care ETF (SPXV) for Q4 2019, worth a combined $44K — down 89% from $383K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SPXV positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $37K. The largest seller was Jane Street, exiting entirely with an estimated $383K sold.
- 3 institutional investors held ProShares S&P 500 ex-Health Care ETF (SPXV) as of Q4 2019, up from 1 in Q3 2019.
- Funds reported $44K of ProShares S&P 500 ex-Health Care ETF stock for Q4 2019, down 89% quarter-over-quarter.
- 3 funds opened new ProShares S&P 500 ex-Health Care ETF positions in Q4 2019 and 1 closed out, a net change of +2 holders.
- The largest ProShares S&P 500 ex-Health Care ETF buyer in Q4 2019 was Bank of America, an estimated $37K added.
- The largest ProShares S&P 500 ex-Health Care ETF seller in Q4 2019 was Jane Street, an estimated $383K sold.
Based on aggregated 13F filings for Q4 2019.